Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Immunogenicity of a Recombinant Human Immunodeficiency Virus (HlV)-Canarypox Vaccine in HlV-Seronegative Ugandan Volunteers: Results of the HIV Network for Prevention Trials 007 Vaccine Study

Autor: HIV Network for Prevention Trials, Cao, H., Kaleebu, P., Hom, D., Flores, J., Agrawal, D., Jones, N., Serwanga, J., Okello, M., Walker, C., Sheppard, H., El-Habib, R., Klein, M., Mbidde, E., Mugyenyi, P., Walker, B., Ellner, J., Mugerwa, R.

Publikováno v: The Journal of Infectious Diseases, 2003 Mar . 187(6), 887-895.

Externí odkaz: https://www.jstor.org/stable/30085777

Pentoxifylline Therapy in Human Immunodeficiency Virus-Seropositive Persons with Tuberculosis: A Randomized, Controlled Trial

Autor: Wallis, R. S., Nsubuga, P., Whalen, C., Mugerwa, R. D., Okwera, A., Oette, D., Jackson, J. B., Johnson, J. L., Ellner, J. J.

Publikováno v: The Journal of Infectious Diseases, 1996 Oct 01. 174(4), 727-733.

Externí odkaz: https://www.jstor.org/stable/30127992

Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion

Autor: Stirrup, O.T. Copas, A.J. Phillips, A.N. Gill, M.J. Geskus, R.B. Touloumi, G. Young, J. Bucher, H.C. Babiker, A.G. Kelleher, T. Cooper, D. Grey, P. Finlayson, R. Bloch, M. Ramacciotti, T. Gelgor, L. Smith, D. Zangerle, R. Gill, J. Lutsar, I. Chêne, G. Dabis, F. Thiebaut, R. Costagliola, D. Guiguet, M. Vanhems, P. Chaix, M.-L. Ghosn, J. Meyer, L. Boufassa, F. Hamouda, O. Meixenberger, K. Bannert, N. Bartmeyer, B. Antoniadou, A. Chrysos, G. Daikos, G.L. Pantazis, N. Katsarou, O. Rezza, G. Dorrucci, M. Monforte, A. Luca, A. Prins, M. Geskus, R. Helm, J. Schuitemaker, H. Sannes, M. Brubakk, O. Kran, A.-M. Rosinska, M. Muga, R. Tor, J. Olalla, P. Cayla, J. Moreno, S. Monge, S. Amo, J. Romero, J. Pérez-Hoyos, S. Sönnerborg, A. Bucher, C. Günthard, H. Scherrer, A. Malyuta, R. Murphy, G. Porter, K. Johnson, A. Babiker, A. Pillay, D. Morrison, C. Salata, R. Mugerwa, R. Chipato, T. Price, M.A. Gilmour, J. Kamali, A. Karita, E. CASCADE Collaboration in EuroCoord

Objectives: To investigate factors that predict speed of recovery and long-term CD4 cell count in HIV-1 seroconverters initiating combination antiretroviral therapy (cART), and to quantify the influence of very early treatment initiation. We make use

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::a760529fd2c2c398bce78c4fbcadf3fe
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3107661

Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4 + T-cell recovery once HIV-1 suppression is achieved?

Autor: Jarrin, I., Pantazis, N., Dalmau, J., Phillips, A. N., Olson, A., Mussini, C., Boufassa, F., Costagliola, D., Porter, K., Blanco, J., Del Amo, J., Martinez-Picado, J., Chene, G., Sabin, C., Walker, S., Fisher, M., Kelleher, T., Cooper, D., Finlayson, R., Bloch, M., Ramacciotti, T., Gelgor, L., Smith, D., Zangerle, R., Gill, J., Lutsar, I., Dabis, F., Thiebaut, R., Guiguet, M., Vanhems, P., Chaix, M. -L., Ghosn, J., Meyer, L., Hamouda, O., Kucherer, C., Bartmeyer, B., Antoniadou, A., Chrysos, G., Daikos, G. L., Touloumi, G., Katsarou, O., Rezza, G., Dorrucci, M., Monforte, A. D., De Luca, A., Prins, M., Geskus, R., Van Der Helm, J., Schuitemaker, H., Sannes, M., Brubakk, O., Kran, A. -M. B., Rosinska, M., Muga, R., Tor, J., De Olalla, P. G., Cayla, J., Moreno, S., Monge, S., Del Romero, J., Perez-Hoyos, S., Sonnerborg, A., Bucher, H. C., Gunthard, H., Rickenbach, M., Malyuta, R., Murphy, G., Johnson, A., Babiker, A., Pillay, D., Morrison, C., Salata, R., Mugerwa, R., Chipato, T., Amornkul, P. N., Gilmour, J., Kamali, A., Karita, E., Burns, F., Giaquinto, C., Grarup, J., Kirk, O., Bailey, H., Anne, A. V., Panteleev, A., Thorne, C., Aboulker, J. -P., Albert, J., Asandi, S., De Wit, S., Reiss, P., Gatell, J., Karpov, I., Ledergerber, B., Lundgren, J., Moller, C., Rakhmanova, A., Rockstroh, J., Sandhu, M., Dedes, N., Fenton, K., Pizzuti, D., Vitoria, M., Faggion, S., Fradette, L., Frost, R., Cartier, A., Raben, D., Schwimmer, C., Scott, M.

Publikováno v: Repisalud
Instituto de Salud Carlos III (ISCIII)
AIDS (London, England)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona

Objective: This article compares trends in CD4þ T-cell recovery and proportions achieving optimal restoration ( 500 cells/ml) after viral suppression following combination antiretroviral therapy (cART) initiation between rapid and nonrapid progresso

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0754ddbdf9794e373fdbac3a8d450243
https://hdl.handle.net/11380/1219798